Effect of O6-methylguanine on DNA interstrand cross-link formation by chloroethylnitrosoureas and 2-chloroethyl(methylsulfonyl)methanesulfonate
- PMID: 2837318
Effect of O6-methylguanine on DNA interstrand cross-link formation by chloroethylnitrosoureas and 2-chloroethyl(methylsulfonyl)methanesulfonate
Abstract
Exposure of HT29 cells in culture to O6-methylguanine is known to result in a reduction in O6-alkylguanine-DNA alkyltransferase (AGT) activity and an enhancement of sensitivity to the cytotoxic effects of chloroethylating agents. Since cytotoxicity of these agents may be mediated by the formation of interstrand cross-links, alkaline elution analysis was performed on HT29 cells treated with 1-(2-chloroethyl)-1-nitrosourea, 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, and Clomesone [2-chloroethyl(methylsulfonyl)methanesulfonate] in the presence or absence of O6-methylguanine pretreatment to determine if the enhanced toxicity was due to an increase in the number of cross-links formed. Interstrand cross-linking by 1-(2-chloroethyl)-1-nitrosourea or 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea was increased by pretreatment with 0.4 mM O6-methylguanine for 24 h. Cross-linking by Clomesone was observed only in cells exposed to 0.4 mM O6-methylguanine for 24 h prior to administration of the drug and for 12 h after administration, suggesting that the resynthesis of the AGT may prevent the cross-linking by Clomesone. Complete recovery of AGT activity after reduction to 20 to 30% of the basal level upon treatment with 0.4 mM O6-methylguanine required between 8 h and 15 h in both HT29 cells and in Raji cells which were also sensitized to 1-(2-chloro-ethyl)-3-cyclohexyl-1-nitrosourea by exposure to O6-methylguanine. These data suggest that the enhancement of chloroethylnitrosourea toxicity after treatment with O6-methylguanine may be related to an increase in the number of DNA cross-links and that the relatively rapid rate of AGT recovery plays a role in prevention of cross-links resulting from Clomesone.
Similar articles
-
Formation of DNA interstrand cross-links by the novel chloroethylating agent 2-chloroethyl(methylsulfonyl)methanesulfonate: suppression by O6-alkylguanine-DNA alkyltransferase purified from human leukemic lymphoblasts.Cancer Res. 1987 Jul 1;47(13):3384-7. Cancer Res. 1987. PMID: 3034412
-
Effect of O6-alkylguanine pretreatment on the sensitivity of human colon tumor cells to the cytotoxic effects of chloroethylating agents.Cancer Res. 1986 Sep;46(9):4500-4. Cancer Res. 1986. PMID: 3015389
-
Effect of O6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents.Cancer Res. 1991 Jul 1;51(13):3367-72. Cancer Res. 1991. PMID: 1647266
-
The role of O-6 methylguanine DNA methyltransferase (MGMT) in drug resistance and strategies for its inhibition.Semin Cancer Biol. 1991 Aug;2(4):257-65. Semin Cancer Biol. 1991. PMID: 1832990 Review.
-
O6-benzylguanine and its role in chemotherapy.Clin Cancer Res. 1997 Jun;3(6):837-47. Clin Cancer Res. 1997. PMID: 9815757 Review.
Cited by
-
Treatment of subcutaneous and intracranial brain tumor xenografts with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea.Cancer Chemother Pharmacol. 1993;32(6):471-6. doi: 10.1007/BF00685892. Cancer Chemother Pharmacol. 1993. PMID: 8258196
-
Potentiation of temozolomide and BCNU cytotoxicity by O(6)-benzylguanine: a comparative study in vitro.Br J Cancer. 1996 Feb;73(4):482-90. doi: 10.1038/bjc.1996.85. Br J Cancer. 1996. PMID: 8595163 Free PMC article.
-
Depletion of O6-alkylguanine-DNA alkyltransferase activity in mammalian tissues and human tumor xenografts in nude mice by treatment with O6-methylguanine.Cancer Chemother Pharmacol. 1989;25(2):103-8. doi: 10.1007/BF00692348. Cancer Chemother Pharmacol. 1989. PMID: 2557168
-
Potential of O6-methylguanine or O6-benzylguanine in the enhancement of chloroethylnitrosourea cytotoxicity on brain tumours.Acta Neurochir (Wien). 1994;128(1-4):13-20. doi: 10.1007/BF01400647. Acta Neurochir (Wien). 1994. PMID: 7847129
-
Enhancement of ACNU cytotoxicity by pretreatment with O6-methylguanine in ACNU-resistant brain tumors.J Neurooncol. 1994;19(1):51-9. doi: 10.1007/BF01051048. J Neurooncol. 1994. PMID: 7815104
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Miscellaneous